As potential predictive markers of molecular-target therapy involving the HGF/MET pathway, amplification and copy number of the MET gene, mRNA expression of MET and HGF, and immunohistochemistry (IHC) of HGF/c-MET have been investigated in GC. The gene discussed is MET; the disease is gastric cancer.